Belite Bio, Inc
147.33USD
-2.9400 (-1.96%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on BLTE.
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -35 | -33 | -28 | -23 | -18 |
| Net Income | -28 | -27 | -25 | -22 | -16 |
| EPS (Diluted) | -$0.70 | -$0.68 | -$0.70 | -$0.65 | -$0.50 |
Source: Yahoo Finance (limited history)